Sherman Matthew L 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Jun 21, 2023
Insider Transaction Report
Form 4
Sherman Matthew L
EVP & Chief Medical Officer
Transactions
- Sale
Common Stock
2023-06-16$14.40/sh−1,655$23,835→ 87,686 total
Footnotes (2)
- [F1]This sale was to cover tax liabilities in the vesting of restricted stock units.
- [F2]Includes 1,196 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 14, 2023.